CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Skye and Redx form new entity with $125M to advance fibrosis assets ","$":{"href":"/biotech/skye-and-redx-form-new-entity-125m-advance-fibrosis-assets","hreflang":"en"}}]}

Positive
AI Analysis

Summary

Skye Bioscience and Redx Pharma have agreed to combine to form Fibrx Therapeutics, a public company funded with $125 million in financing to advance fibrosis disease assets.

Outcome Details

Combination agreement forming new public company

Importance:7/10
Sentiment:
0.60
M&Amergerfibrosisfinancingpublic company
Related Companies

Read the original article

Published by FierceBiotech on August 14, 2026 12:28 PM

Read Original